Merck reports surging sales of vaccines and key cancer drug - Washington Post

Merck reports surging sales of vaccines and key cancer drug  Washington Post

Merck breezed past almost all expectations for the first quarter with global sales jumping 8 percent to almost $11 billion.



Comments

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Stage 4 Lung Cancer Life Expectancy

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...